Clinical significance of estrogen receptor β in breast and prostate cancer from biological aspects

E-ISSN： 1349-7006|106|4|337-343

ISSN： 1347-9032

Source： Cancer Science, Vol.106, Iss.4, 2015-04, pp. : 337-343

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic advances in BIG3‐PHB2 inhibition targeting the crosstalk between estrogen and growth factors in breast cancer

Cancer Science, Vol. 106, Iss. 5, 2015-05 ,pp. : 550-558

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical significance of tumor‐infiltrating immune cells focusing on BTLA and Cbl‐b in patients with gallbladder cancer

Cancer Science, Vol. 106, Iss. 12, 2015-12 ,pp. : 1750-1760

John Wiley & Sons Inc

Access to resources Recommend Favorite

Husband's smoking status and breast cancer risk in Japan: From the Takayama study

Cancer Science, Vol. 106, Iss. 4, 2015-04 ,pp. : 455-460

John Wiley & Sons Inc

Access to resources Recommend Favorite

Epidermal growth factor receptor and AKT1 gene copy numbers by multi‐gene fluorescence in situ hybridization impact on prognosis in breast cancer

Cancer Science, Vol. 106, Iss. 5, 2015-05 ,pp. : 642-649

John Wiley & Sons Inc

Access to resources Recommend Favorite

Downregulation of 15‐hydroxyprostaglandin dehydrogenase by interleukin‐1β from activated macrophages leads to poor prognosis in pancreatic cancer

Cancer Science, Vol. 109, Iss. 2, 2018-02 ,pp. : 462-470

John Wiley & Sons Inc

Access to resources Recommend Favorite